Boston Scientific price target raised to $120 from $115 at Stifel
Stifel raised the firm’s price target on Boston Scientific (BSX) to $120 from $115 and keeps a Buy rating on the shares after having hosted ...
Barclays Reaffirms Their Buy Rating on Boston Scientific (BSX)
In a report released today, Matt Miksic from Barclays maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target ...
Stifel raises Boston Scientific stock target to $120, keeps buy rating
Stifel analysts increased their price target on Boston Scientific Corporation (NYSE:BSX) shares from $115.00 to $120.00, while reiterating a Buy rating for the medical device company. The adjustment ...